Skip to main content

Clinical trial MCLA-158-CL01

Phase 1 dose escalation and cohort expansion study evaluating single-agent MCLA-158 in metastatic colorectal cancer and other advanced solid tumors

Organ solid tumors
Trial status Trial open for recruitment
Trial type
Prospective interventional
Phase Trial phase 1
Academic trial Non
Sponsor Merus
EudraCT Identifier 2017-004745-24
Inclusion criteria Metastatic Biopsy mandatory
Last update

Follow us!

Support research

Support research

Research at the Institut Jules Bordet depends on your generosity. Make a donation today and join us in the fight against cancer.

Learn more